ISO 9001:2015 Certified
Live Customer Support
4.5/5 on Trustpilot
100% Quality Guarantee

Recombinant Anti-Cytokeratin 8 Antibody [KRT8/4067R] - BSA and Azide free (A252338)

Recombinant rabbit monoclonal [KRT8/4067R] antibody to Cytokeratin 8 for Flow Cytometry, WB, IF and IHC-P.

Alternative Formats and ConjugatesAlternative Formats

Shipping Information

$40
Dispatched from St. Louis, MO.
Lead Time: 5-8 business days.
Name
Anti-Cytokeratin 8 Antibody [KRT8/4067R] - BSA and Azide free
Description
Recombinant rabbit monoclonal [KRT8/4067R] antibody to Cytokeratin 8.
Applications
Flow Cytometry, WB, IF, IHC-P
Dilutions
Flow Cytometry: 1-2 µg/million cells, WB: 1-2 µg/ml, IF: 1-2 µg/ml, WB: 2-4 µg/ml, IHC-P: 1-2 µg/ml
Reactivity
Human
Cross Reactivity
This antibody does not cross react with Rat.
Immunogen
Keratin preparation from a human carcinoma.
Host
Rabbit
Clonality
Monoclonal
Clone ID
KRT8/4067R
Isotype
IgG
Conjugate

Unconjugated

Purification
Protein A/G chromatography.
Concentration
1 mg/ml
Molecular Weight
52.5 kDa
Product Form
Liquid
Formulation
Supplied in 10mM Phosphate Buffered Saline; without Sodium Azide and carrier free.
Storage
Shipped at 4°C. Upon delivery aliquot and store at -20°C. Avoid freeze / thaw cycles.
General Notes
This monoclonal antibody is also available in a different formulation with BSA and Sodium Azide - Anti-Cytokeratin 8 Antibody [KRT8/4067R] (A249158).
Synonyms
CK-8, CYK8, Cytokeratin-8, K8, Keratin, type II cytoskeletal 8, Keratin-8, KRT8, Type-II keratin Kb8
Disclaimer
This product is for research use only. It is not intended for diagnostic or therapeutic use.
Publishing research using Recombinant Anti-Cytokeratin 8 Antibody [KRT8/4067R] - BSA and Azide free (A252338)? Please let us know so that we can list the citation on this page.

Alternative products to Anti-Cytokeratin 8 Antibody [KRT8/4067R] - BSA and Azide free (A252338)

Proteins predicted to interact with Cytokeratin 8

Predicted protein interactions based upon String database. Revelancy score correlates with probability of interaction.
99.9% Relevancy Score
86.9% Relevancy Score
84.5% Relevancy Score
82.6% Relevancy Score
79.8% Relevancy Score
79.6% Relevancy Score
79.1% Relevancy Score
78.3% Relevancy Score
76.3% Relevancy Score